AI English summary of an SEC filing — figures as filed
HCA Healthcare HCAThe company said revenue for Q2 2026 rose 8.7% to $20.230 billion, and net income attributable to HCA Healthcare, Inc. was $1.699 billion, or $7.62 per diluted share.
Key points
AI summaryThe company said revenue for Q2 2026 rose 8.7% to $20.230 billion, and net income attributable to HCA Healthcare, Inc. was $1.699 billion, or $7.62 per diluted share.
HCA Healthcare said the payer mix shift, driven by higher uninsured volume, had an unfavorable impact on income before income taxes of approximately $400 million in Q2. It also said it recognized an incremental net benefit of approximately $400 million from Medicaid Supplemental Payment Programs.
Operating cash flow for Q2 was $2.335 billion, compared with $4.210 billion in the prior-year quarter. The company also said it repurchased 4.752 million shares at a cost of $2.064 billion during the same quarter.
The company said it revised its 2026 full-year guidance, with revenues of $77.000 to $79.500 billion, Adjusted EBITDA of $15.400 to $16.100 billion, and diluted EPS of $28.70 to $30.50.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q2 Revenue, Net Income and Diluted EPS
The company said revenue for Q2 2026 rose 8.7% to $20.230 billion, and net income attributable to HCA Healthcare, Inc. was $1.699 billion, or $7.62 per diluted share.
Source · Based on the filing body and exhibits
Payer Mix Shifts and Medicaid Supplemental Payment Effects
HCA Healthcare said the payer mix shift, driven by higher uninsured volume, had an unfavorable impact on income before income taxes of approximately $400 million in Q2. It also said it recognized an incremental net benefit of approximately $400 million from Medicaid Supplemental Payment Programs.
Source · Based on the filing body and exhibits
Q2 Operating Cash Flow and Share Repurchases
Operating cash flow for Q2 was $2.335 billion, compared with $4.210 billion in the prior-year quarter. The company also said it repurchased 4.752 million shares at a cost of $2.064 billion during the same quarter.
Source · Based on the filing body and exhibits
2026 Full-Year Outlook Revised
The company said it revised its 2026 full-year guidance, with revenues of $77.000 to $79.500 billion, Adjusted EBITDA of $15.400 to $16.100 billion, and diluted EPS of $28.70 to $30.50.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…